These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22823204)

  • 1. Advances in computational methods to predict the biological activity of compounds.
    Nantasenamat C; Isarankura-Na-Ayudhya C; Prachayasittikul V
    Expert Opin Drug Discov; 2010 Jul; 5(7):633-54. PubMed ID: 22823204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in quantitative structure-activity relationship models of antimalarials.
    Roy K; Ojha PK
    Expert Opin Drug Discov; 2010 Aug; 5(8):751-78. PubMed ID: 22827798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational methods to predict the reactivity of nanoparticles through structure-property relationships.
    Poater A; Gallegos Saliner A; Solà M; Cavallo L; Worth AP
    Expert Opin Drug Deliv; 2010 Mar; 7(3):295-305. PubMed ID: 20201736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational systems approach for drug target discovery.
    Chandra N
    Expert Opin Drug Discov; 2009 Dec; 4(12):1221-36. PubMed ID: 23480463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What does systems biology mean for biomarker discovery?
    Azuaje F
    Expert Opin Med Diagn; 2010 Jan; 4(1):1-10. PubMed ID: 23496106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biasing conformational ensembles towards bioactive-like conformers for ligand-based drug design.
    Musafia B; Senderowitz H
    Expert Opin Drug Discov; 2010 Oct; 5(10):943-59. PubMed ID: 22823989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational tools for the modern andrologist.
    Niederberger C
    J Androl; 1996; 17(5):462-6. PubMed ID: 8957688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systems biology visualization tools for drug target discovery.
    Huan T; Wu X; Chen JY
    Expert Opin Drug Discov; 2010 May; 5(5):425-39. PubMed ID: 22823128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the discovery and evaluation of fatty acid amide hydrolase inhibitors.
    Deng H
    Expert Opin Drug Discov; 2010 Oct; 5(10):961-93. PubMed ID: 22823990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for computational screening of non-steroidal androgen receptor ligands.
    Nyrönen TH; Söderholm AA
    Expert Opin Drug Discov; 2010 Jan; 5(1):5-20. PubMed ID: 22823968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico fragment-based drug design.
    Konteatis ZD
    Expert Opin Drug Discov; 2010 Nov; 5(11):1047-65. PubMed ID: 22827744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo design: balancing novelty and confined chemical space.
    Kutchukian PS; Shakhnovich EI
    Expert Opin Drug Discov; 2010 Aug; 5(8):789-812. PubMed ID: 22827800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunities and limits of cell-based assay miniaturization in drug discovery.
    Carstens C; Elbracht R; Gärtner C; Becker H
    Expert Opin Drug Discov; 2010 Jul; 5(7):673-9. PubMed ID: 22823206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural ensemble in computational drug screening.
    Fukunishi Y
    Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):835-49. PubMed ID: 20465522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease state.
    Feng B; LaPerle JL; Chang G; Varma MV
    Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):939-52. PubMed ID: 20433402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of estrogen receptor modulators: a review of virtual screening and SAR efforts.
    Xu X; Yang W; Li Y; Wang Y
    Expert Opin Drug Discov; 2010 Jan; 5(1):21-31. PubMed ID: 22823969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of in silico and in vitro tools for scaffold optimization during drug discovery: predicting P-glycoprotein efflux.
    Desai PV; Sawada GA; Watson IA; Raub TJ
    Mol Pharm; 2013 Apr; 10(4):1249-61. PubMed ID: 23363443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using artificial neural networks to predict cell-penetrating compounds.
    Karelson M; Dobchev D
    Expert Opin Drug Discov; 2011 Aug; 6(8):783-96. PubMed ID: 22651123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.